Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Contract Wins

12 Jun 2024 07:00

RNS Number : 0440S
Checkit PLC
12 June 2024
 

12 June 2024

 

Checkit plc

("Checkit" or the "Group")

 

Contract Wins

 

Checkit (AIM: CKT), the automated monitoring platform for operational leaders, is pleased to announce a significant expansion with an existing US customer and a first customer for the recently launched AI module.

 

Contract Wins

 

The Group announces a significant expansion with Octaphama Plasma in the United States worth c.£718,000 over three years.

 

Octapharma will be expanding their use of the Checkit platform by integrating TTMUs (Tactical Temperature Monitoring Units) into their existing monitoring system, further protecting their operational data and mission-critical inventory. By leveraging the TTMUs offline data logging capabilities, Octapharma will have complete data redundancy across their entire network of plasma donation centres in the US. The investment highlights Octapharma's ongoing commitment to ensuring the safety and security of their plasma and operational data.

 

The Group is also pleased to announce a first signed contract for the recently launched Asset Intelligence product module, which applies advanced analytics and Machine Learning to IoT data which will help enhance customer sustainability, reduce costs, and improve revenue.

 

Commenting on the news Kit Kyte, Chief Executive Officer, said: "This latest win continues to validate our 'land and expand' strategy and demonstrates continued momentum in the US, a strategic priority for the business. Forward-thinking leaders like Octapharma understand why it's so critical to execute an operational data strategy, and we appreciate their trust and partnership. I am also thrilled that we have secured our first customer for the recently launched Asset Intelligence module, which marks the start of an exciting chapter in the evolution of our offering and our integrated end-to-end platform."

 

For further information, please visit www.checkit.net or contact:

 

Checkit plc

Kit Kyte (Chief Executive Officer)

Greg Price (Chief Financial and Operations Officer)

+44 (0) 1223 643313

Singer Capital Markets (Nominated Adviser & Broker)

Shaun Dobson / Peter Steel / James Fischer

+44 (0) 20 7496 3000

Tavistock (Financial PR)

Lulu Bridges / Katie Hopkins / Simon Hudson

+44 (0) 20 7920 3150

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFLFITRLILLIS
Date   Source Headline
15th Oct 200810:04 amRNSHolding(s) in Company
13th Oct 20084:33 pmRNSDirector/PDMR Shareholding
6th Oct 200812:46 pmRNSDirector/PDMR Shareholding
11th Sep 20084:54 pmRNSHolding(s) in Company
4th Aug 20087:00 amRNSDirector/PDMR Shareholding
29th Jul 20085:22 pmRNSResult of AGM
23rd Jul 20087:00 amRNSDirector/PDMR Shareholding
15th Jul 20088:49 amRNSAnnual Report and Accounts
9th Jul 20087:00 amRNSDirector/PDMR Shareholding
8th Jul 20087:00 amRNSDirectorate Change
8th Jul 20087:00 amRNSDirector/PDMR Shareholding
27th Jun 200812:53 pmRNSHolding(s) in Company
25th Jun 20082:09 pmRNSHolding(s) in Company
19th Jun 20088:28 amRNSTransaction in Own Shares
18th Jun 20087:00 amRNSTransaction in Own Shares
12th Jun 20087:00 amRNSFinal Results
9th Jun 20087:00 amRNSDirectorate Change
28th Apr 200811:58 amRNSDirectorate Change
11th Apr 20087:00 amRNSChange of Adviser
31st Mar 20089:21 amRNSTotal Voting Rights
10th Mar 20083:58 pmRNSShare Repurchase
4th Mar 20087:00 amRNSTrading Update
31st Oct 200710:19 amRNSSignificant Shareholder
25th Oct 20077:00 amRNSInterim Results
21st Sep 20071:03 pmRNSSignificant Shareholder
21st Sep 20079:52 amRNSSignificant Shareholder
6th Sep 20079:20 amRNSSignificant Shareholding
6th Sep 20077:01 amRNSDisposal
5th Sep 200710:22 amRNSHolding(s) in Company
15th Aug 20077:01 amRNSDirectors' Dealings
10th Aug 20077:01 amRNSSifam Properties Disposal
9th Aug 20077:01 amRNSSifam Instruments Acquisition
31st Jul 20072:59 pmRNSRule 26 Website
23rd Jul 200710:02 amRNSAnnual Report and Accounts
28th Jun 20077:01 amRNSPreliminary Results
1st May 20072:48 pmRNSSignificant Holding
23rd Mar 20077:30 amRNSDisposal
19th Mar 200711:14 amRNSChange of Registered Office
1st Feb 20077:01 amRNSFreehold Properties Disposal
24th Jan 20071:25 pmRNSSignificant Shareholding
18th Dec 200610:08 amRNSTotal Voting Rights
18th Dec 20069:57 amRNSOffer Update
14th Dec 20063:08 pmRNSSignificant Shareholding
11th Dec 20061:01 pmRNSIssue of Equity
29th Nov 20062:12 pmRNSIssue of Equity
23rd Nov 20069:48 amRNSIssue of Equity
13th Nov 20065:28 pmRNSIssue of Equity
6th Nov 20063:18 pmRNSOffer Update
23rd Oct 200610:08 amRNSOffer Update
19th Oct 20065:40 pmRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.